Ignacio Durán
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 39
-
- Renal cell carcinoma treatment 40
- Prostate Cancer Treatment and Research 23
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 20
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 65
- Urinary and Genital Oncology Studies 41
- Neurology top 5%
-
- Renal and related cancers 16
-
- Radiopharmaceutical Chemistry and Applications 15
- Co-authors
- Daniel CastellanoYohann LoriotCarmen GarrigósSaman Maleki VarekiThomas PowlesJonathan E. RosenbergDaniel P. PetrylakChunzhang Wu
- Journals
- Journal of Clinical Oncology (73 papers)Annals of Oncology (23 papers)Clinical & Translational Oncology (16 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Ignacio Durán
198 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 2.3k
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 562
- Surgery 1.6k
- Neurology 415
Countries citing papers authored by Ignacio Durán
This map shows the geographic impact of Ignacio Durán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Durán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Durán more than expected).
Fields of papers citing papers by Ignacio Durán
This network shows the impact of papers produced by Ignacio Durán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Durán. The network helps show where Ignacio Durán may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ignacio Durán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 1 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 3 | |
| 14 | 2018 | 3 | |
| 15 | 2017 | 17 | |
| 16 | 2016 | 2 | |
| 17 | 2013 | 1 | |
| 18 | 2012 | 76 | |
| 19 | 2011 | 83 | |
| 20 | 2011 | 3 |
About Ignacio Durán
Ignacio Durán is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 206 papers that have together received 4.8k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (65 papers), Urinary and Genital Oncology Studies (41 papers), Renal cell carcinoma treatment (40 papers), Cancer Immunotherapy and Biomarkers (39 papers), Prostate Cancer Treatment and Research (23 papers), Cancer Genomics and Diagnostics (20 papers), Renal and related cancers (16 papers) and Radiopharmaceutical Chemistry and Applications (15 papers). The work is most often cited by research in Oncology (2.3k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cancer Research (562 citations). Ignacio Durán has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Daniel Castellano, Yohann Loriot, Carmen Garrigós, Saman Maleki Vareki, Thomas Powles, Jonathan E. Rosenberg, Daniel P. Petrylak, Chunzhang Wu, Guru Sonpavde and Christof Vulsteke. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical & Translational Oncology, European Urology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.